Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease	Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy	Recruiting	Phase 3	2026-02-06		NCT07062198

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
ScandiBio Therapeutics AB	1

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ataturk University, Faculty of Medicine, Department of Neurology, Erzurum, Turkey; Movement Disorders and Neuromodulation Center, Ataturk University	Erzurum	Turkey (Türkiye)	1
Behavioural Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University	Istanbul	Turkey (Türkiye)	1
Department of Neurology and Neuroscience, Faculty of Medicine, Alaaddin Keykubat University	Alanya	Turkey (Türkiye)	1
Haydarpaşa Numune Training and Research Hospital, University of Health Sciences Istanbul	Istanbul	Turkey (Türkiye)	1
Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, University of Health Sciences Istanbul	Istanbul	Turkey (Türkiye)	1
SB Haseki Training and Research Hospital, Istanbul, University of Health Sciences Istanbul	Istanbul	Turkey (Türkiye)	1
Sultan Abdülhamid Han Training and Research Hospital, University of Health Sciences Istanbul	Istanbul	Turkey (Türkiye)	1
Umraniye Training and Research Hospital, University of Health Sciences Istanbul	Istanbul	Turkey (Türkiye)	1